UNDERSTANDING CURRENT PRACTICES FOR FUROSEMIDE ADMINISTRATION TO INPATIENTS WITH ACUTE DECOMPENSATED HEART FAILURE: OPPORTUNITIES FOR QUALITY IMPROVEMENT